Advertisement

Rheumatology International

, Volume 13, Issue 4, pp 151–154 | Cite as

Abnormal T-cell function in patients with psoriatic arthritis: evidence for decreased interleukin 2 production

  • J. G. Fort
  • J. B. Smith
  • J. L. Abruzzo
Originals

Summary

Psoriatic arthritis (PSA) is an inflammatory arthritis associated with psoriasis. Although not considered an autoimmune process, there is evidence for humoral and cellular immune abnormalities similar to autoimmune diseases such as rheumatoid arthritis and systemic lupus (SLE). We investigated mitogen-induced proliferation and interleukin 2 (IL-2) production by peripheral blood mononuclear cells in patients with PSA. Both IL-2 production and proliferation were significantly decreased in PSA patients when compared to controls. Increased arachidonic acid metabolism has been reported in skin and peripheral mononuclear cells of patients with psoriasis and PSA. We therefore also investigated the effect of indomethacin and prostaglandin E2 (PGE2) on IL-2 production. Addition of indomethacin to cultures did not significantly change IL-2 production in patients with PSA, but did so in controls. PGE2 produced a significant reduction in IL-2 production in PSA and in controls.

Key words

Psoriatic arthritis Interleukin 2 Prostaglandins 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Espinoza LR (1985) Psoriatic arthritis: further epidemiologic and genetic considerations. In: Gerber LH, Espinoza LR (eds) Psoriatic arthritis. Grune & Stratton, Orlando, p 9Google Scholar
  2. 2.
    Laurent MR, Panayi GS, Shepard P (1981) Circulating immune complexes, serum immunoglobins and acute phase proteins in psoriasis and psoriatic arthritis. Ann Rheum Dis 40:66–99Google Scholar
  3. 3.
    Sany J, Clot J (1980) Immunologic abnormalities in psoriatic arthropathy. J Rheumatol 7:438–444Google Scholar
  4. 4.
    Leonard DG, O'Duffy JD, Rogers RS (1978) Prospective analysis of psoriatic arthritis patients hospitalized for psoriasis. Mayo Clin Proc 53:511–518Google Scholar
  5. 5.
    Espinoza LR, Gaylord SW, Vasey FB, Osterland CK (1979) Cell-mediated immunity in psoriatic arthritis. J Rheumatol 7:218–224Google Scholar
  6. 6.
    Rubins AY, Merson AG (1987) Subpopulations of T lymphocytes in psoriasis patients and their changes during immunotherapy. J Am Acad Dermatol 17:972–977Google Scholar
  7. 7.
    Gladman DD, Keystone EC, Schacter RK (1983) Aberration in T-cell subpopulations in patients with psoriasis and psoriatic arthritis. J Invest Dermatol 80:286–290Google Scholar
  8. 8.
    Smith MD, Roberts-Thompson PJ (1989) Interleukin 2 and interleukin 2 inhibitors in human serum and synovial fluid. II. Mitogenic stimulation, interleukin 2 production and interleukin 2 receptor expression in rheumatoid arthritis, psoriatic arthritis and Reiter's syndrome. J Rheumatol 16:897–903Google Scholar
  9. 9.
    Miyasaka N, Nakamura T, Russell IJ, Talal N (1984) Interleukin 2 deficiencies in rheumatoid arthritis and systemic lupus erythematosus. Clin Immunopathol 31:109–117Google Scholar
  10. 10.
    Kitas GD, Salmon M, Farr M, Gaston JSH, Bacon PA (1988) Deficient interleukin 2 production in rheumatoid arthritis: association with disease activity and systemic complications. Clin Exp Immunol 73:242–249Google Scholar
  11. 11.
    Moll JMH, Wright V (1973) Psoriatic arthritis. Semin Arthritis Rheum 3:55–78Google Scholar
  12. 12.
    Gillis S, Ferm MM, Ou W, Smith KA (1978) T cell growth factor: parameters of production and a quantitative microassay for activity. J Immunol 120:2027–2032Google Scholar
  13. 13.
    Bocchieri MH, Smith JB, Staruch NJ, Wood DD (1985) Functional consequence of perceived interleukin deficiencies? Analysis employing NZB X C58 recombinant inbred mice. Clin Exp Immunol 62:622–629Google Scholar
  14. 14.
    Emery P, Wood N, Gentry K, Stockman A, Mackay IR, Bernard O (1988) High affinity interleukin 2 receptors on blood lymphocytes are decreased during active rheumatoid arthritis. Arthritis Rheum 31:1176–1181Google Scholar
  15. 15.
    Ishida H, Kumagai S, Umehara H, Sano H, Tagaya Y, Yodoi J, Imura H (1987) Impaired expression of high affinity interleukin 2 receptor on activated lymphocytes from patients with systemic lupus erythematosus. J Immunol 139:1070–1074Google Scholar
  16. 16.
    Miossec P (1993) Interleukin 4. A potential anti-inflammatory agent. Rev Rheum 60:87–90Google Scholar
  17. 17.
    Holter W (1992) Regulation of interleukin 4 production and of interleukin 4 producing cells. Int Arch Allergy Immunol 98:273–278Google Scholar
  18. 18.
    Kragballe K, Voorhees JJ (1985) Arachidonic acid and leukotriens in pathogenesis and treatment. In: Roenigk HH, Malbach HI (eds) Psoriasis, Dekker, New York, pp 255–263Google Scholar
  19. 19.
    Lew W, Oppenhelm JJ, Matsushlama K (1988) Analysis of the supression of IL-1 alpha and IL-1 beta production in human peripheral blood mononuclear adherent cells by a glucocorticold hormone. J Immunol 140:1895–1902Google Scholar
  20. 20.
    Knudsen PJ, Dinarello CA, Strom TB (1986) Prostaglandins posttranscriptionally inhibit monocyte expression on interleukin 1 activity by increasing intracellular cyclic adenosine monophosphate. J Immunol 137:3189–3194Google Scholar
  21. 21.
    Chouaib S, Welte K, Mertelsmann R, Dupont B (1985) Prostaglandin E2 acts on two distinct pathways of T lymphocyte activation: inhibition of interleukin 2 production and down regulation of transferrin receptor expression. J Immunol 135:1172–1179Google Scholar
  22. 22.
    Walker C, Kristensen F, Bettens F, DeWeck AL (1983) Lymphokine regulation of activated (G1) lymphocytes. Prostaglandin E2 induced inhibition of interleukin 2 production. J Immunol 130:1770–1773Google Scholar
  23. 23.
    Rappaport RS, Dodge GR (1982) Prostaglandin E inhibits the production of human interleukin 2. J Exp Med 155:943–948Google Scholar
  24. 24.
    Numo R, Lapadula G (1987) Present status and new perspectives in nonsteroidal anti-inflammatory drugs therapy, Scand J Rheumatol [Suppl] 66:75–83Google Scholar

Copyright information

© Springer-Verlag 1993

Authors and Affiliations

  • J. G. Fort
    • 1
  • J. B. Smith
    • 1
  • J. L. Abruzzo
    • 1
  1. 1.Division of RheumatologyJefferson Medical CollegePhiladelphiaUSA

Personalised recommendations